Karin Söderberg

1.7k total citations
34 papers, 1.2k citations indexed

About

Karin Söderberg is a scholar working on Epidemiology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Karin Söderberg has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Karin Söderberg's work include Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (3 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). Karin Söderberg is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (3 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). Karin Söderberg collaborates with scholars based in Sweden, United States and Finland. Karin Söderberg's co-authors include Maria Feychting, Fredrik Jönsson, Judith Schwartzbaum, Lars Hagmar, Jette Möller, Lucie Laflamme, Pär Sparén, Anders Ahlbom, Stefan Lönn and Susan Preston‐Martin and has published in prestigious journals such as Scientific Reports, Annals of the New York Academy of Sciences and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Karin Söderberg

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Söderberg Sweden 18 214 211 209 208 151 34 1.2k
P. Disdier France 20 118 0.6× 117 0.6× 296 1.4× 221 1.1× 173 1.1× 149 1.5k
Carlos Cantú‐Brito Mexico 20 187 0.9× 137 0.6× 108 0.5× 348 1.7× 63 0.4× 121 1.2k
Carmen Martín Spain 23 104 0.5× 177 0.8× 255 1.2× 730 3.5× 125 0.8× 80 1.7k
Jacques Serratrice Switzerland 20 143 0.7× 122 0.6× 210 1.0× 291 1.4× 539 3.6× 98 1.7k
Esther Bächli Switzerland 21 136 0.6× 99 0.5× 174 0.8× 183 0.9× 137 0.9× 53 1.7k
J. Lepercq France 24 279 1.3× 210 1.0× 395 1.9× 544 2.6× 392 2.6× 97 3.0k
Jaime Masjuán Spain 25 291 1.4× 390 1.8× 105 0.5× 1.1k 5.2× 73 0.5× 150 2.6k
Peter Rosenberger Germany 20 465 2.2× 163 0.8× 378 1.8× 205 1.0× 25 0.2× 90 1.3k
Steven K. Feske United States 23 182 0.9× 64 0.3× 169 0.8× 704 3.4× 75 0.5× 63 2.5k
Jason J. Chang United States 31 197 0.9× 281 1.3× 263 1.3× 1.2k 5.8× 59 0.4× 94 2.4k

Countries citing papers authored by Karin Söderberg

Since Specialization
Citations

This map shows the geographic impact of Karin Söderberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Söderberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Söderberg more than expected).

Fields of papers citing papers by Karin Söderberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Söderberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Söderberg. The network helps show where Karin Söderberg may publish in the future.

Co-authorship network of co-authors of Karin Söderberg

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Söderberg. A scholar is included among the top collaborators of Karin Söderberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Söderberg. Karin Söderberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Grote, Ludger, Danielle Friberg, Jonas Spaak, et al.. (2023). National Knowledge-Driven Management of Obstructive Sleep Apnea—The Swedish Approach. Diagnostics. 13(6). 1179–1179. 10 indexed citations
4.
5.
Rashid, Mamun-Ur, Staffan Rosenborg, Georgios Panagiotidis, et al.. (2015). Ecological effect of ceftazidime/avibactam on the normal human intestinal microbiota. International Journal of Antimicrobial Agents. 46(1). 60–65. 29 indexed citations
6.
Sundström, Karin, Caroline E. Weibull, Karin Söderberg, et al.. (2015). Incidence of herpes zoster and associated events including stroke—a population-based cohort study. BMC Infectious Diseases. 15(1). 488–488. 55 indexed citations
7.
Möller, Jette, Lucie Laflamme, & Karin Söderberg. (2014). CYP2D6‐Inhibiting Drugs and the Increased Risk of Fall‐Related Injuries Due to Newly Initiated Opioid Treatment – ASwedish, Register‐Based Case‐Crossover Study. Basic & Clinical Pharmacology & Toxicology. 116(2). 134–139. 10 indexed citations
8.
Olivecrona, H., Karin Söderberg, B. Hallén, et al.. (2013). OP0061 Kineret® (Anakinra) Controls Disease Symptoms in Patients with Severe Cryopyrin-Associated Periodic Syndromes (CAPS): Up to 5-Year Follow-Up Data. Annals of the Rheumatic Diseases. 72. A70–A71. 2 indexed citations
9.
Leinonen, M., Karin Söderberg, H. Olivecrona, et al.. (2013). SAT0440 The IL-1RA Antagonist Kineret® (Anakinra) Stabilizes Hearing Loss in Patients with Severe Cryopyrin-Associated Periodic Syndromes (CAPS). Annals of the Rheumatic Diseases. 72. A730–A731. 1 indexed citations
10.
Söderberg, Karin, Lucie Laflamme, & Jette Möller. (2013). Newly Initiated Opioid Treatment and the Risk of Fall-Related Injuries. CNS Drugs. 27(2). 155–161. 70 indexed citations
11.
Söderberg, Karin, Marine L. Andersson, & Lars L. Gustafsson. (2013). Cytochrome P450-Mediated Changes in Oxycodone Pharmacokinetics/Pharmacodynamics and Their Clinical Implications. Drugs. 73(6). 533–543. 44 indexed citations
12.
Lundqvist, E, Jaakko Kaprio, Pia K. Verkasalo, et al.. (2007). Co‐twin control and cohort analyses of body mass index and height in relation to breast, prostate, ovarian, corpus uteri, colon and rectal cancer among Swedish and Finnish twins. International Journal of Cancer. 121(4). 810–818. 38 indexed citations
13.
Söderberg, Karin, Inger Sundström Poromaa, Sigrid Nyberg, Torbjörn Bäckström, & Erik Nordh. (2006). Psychophysically Determined Thresholds for Thermal Perception and Pain Perception in Healthy Women Across the Menstrual Cycle. Clinical Journal of Pain. 22(7). 610–616. 32 indexed citations
14.
Söderberg, Karin, Fredrik Jönsson, Ola Winqvist, Lars Hagmar, & Maria Feychting. (2006). Autoimmune diseases, asthma and risk of haematological malignancies: A nationwide case-control study in Sweden. European Journal of Cancer. 42(17). 3028–3033. 79 indexed citations
15.
Schwartzbaum, Judith, Fredrik Jönsson, Anders Ahlbom, et al.. (2005). Prior Hospitalization for Epilepsy, Diabetes, and Stroke and Subsequent Glioma and Meningioma Risk. Cancer Epidemiology Biomarkers & Prevention. 14(3). 643–650. 54 indexed citations
16.
Söderberg, Karin, Lars Hagmar, Judith Schwartzbaum, & Maria Feychting. (2004). Allergic conditions and risk of hematological malignancies in adults: a cohort study. BMC Public Health. 4(1). 51–51. 61 indexed citations
17.
Söderberg, Karin, et al.. (2002). Childhood Leukemia and Magnetic Fields in Infant Incubators. Epidemiology. 13(1). 45–49. 17 indexed citations
18.
Fiessinger, Jean‐Noël, María Fernanda López Fernández, S. Granqvist, et al.. (1996). Once-daily Subcutaneous Dalteparin, a Low Molecular Weight Heparin, for the Initial Treatment of Acute Deep Vein Thrombosis. Thrombosis and Haemostasis. 76(2). 195–199. 118 indexed citations
19.
Palm, M., et al.. (1989). Antithrombotic Effects of Heparin Oligosaccharides. Annals of the New York Academy of Sciences. 556(1). 323–332. 8 indexed citations
20.
Holmer, E., Karin Söderberg, David Bergqvist, & Ulf Lindahl. (1986). Heparin and Its Low Molecular Weight Derivatives: Anticoagulant and Antithrombotic Properties. Pathophysiology of Haemostasis and Thrombosis. 16(Suppl. 2). 1–7. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Disdier Breakdown of academic impact, for papers by Carlos Cantú‐Brito Breakdown of academic impact, for papers by Carmen Martín Breakdown of academic impact, for papers by Jacques Serratrice Breakdown of academic impact, for papers by Esther Bächli Breakdown of academic impact, for papers by J. Lepercq Breakdown of academic impact, for papers by Jaime Masjuán Breakdown of academic impact, for papers by Peter Rosenberger Breakdown of academic impact, for papers by Steven K. Feske Breakdown of academic impact, for papers by Jason J. Chang
Rankless by CCL
2026